BioSpace News Archive

Luminex Corporation announced 4th quarter 2020 revenue of approximately $111M, up approximately 23% over the 4th quarter of 2019 and full-year revenue of approximately $417M, up approximately 25% over the full year 2019.

Opticyte Secures $4.6 Million in Funding to Develop First Cell O 2 Monitor for Reducing Organ Failure Opticyte obtains funding from a $2.9MM SBIR Phase IIB grant and completes a $1.7MM seed round to launch first observational trial of Opticyte Cell O 2 Monitor

n, a privately held Minneapolis company, announces that they treated their first patient in a phase one human trial of a new treatment developed to combat recurrent high-grade brain tumors.

ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a new clinical trial evaluating the efficacy of cannabidiol in ANANDA’s proprietary delivery technology as a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms and Neurocognitive Impairment in patients with PTSD and with PTSD comorbid with traumatic brain injury. An Investigational New Drug (IND)

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in adults 18 years of age and older.

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, today announced that it has signed a licensing and commercialization agreement with CanProbe for exclusive rights to Lutetium – 177 Octreotate (Lu-DOTATATE) for the treatment of neuroendocrine cancer. CanProbe, a joint venture between the University Health Network (UHN) and the Centre for Probe Develo

The global healthcare IT market is brimming with opportunities as health information technology has revolutionized patient care and healthcare services across the world.

The demand within the global invisible orthodontics market is set to rise at a boisterous pace in the years to follow. Advancements in dentistry have come as a welcome feat for the medical industry.

The need for freeze-drying has become a necessity across the food and pharmaceutical industry, and this factor has driven demand within the global lyophilization equipment and services market.

The global cell lines market is expected to ride on the back of surging applications in research, especially in biochemistry, cell biology, cancer diagnostics, drug discovery and molecular biology.